{
    "2019-05-10": [
        [
            {
                "time": "2018-04-25",
                "original_text": "Equifax's (EFX) Q1 Earnings Beat Estimates, Revenues Lag",
                "features": {
                    "keywords": [
                        "Equifax",
                        "Q1 Earnings",
                        "Beat Estimates",
                        "Revenues Lag"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "Charles River Associates (CRAI) Lags Q1 Earnings Estimates",
                "features": {
                    "keywords": [
                        "Charles River Associates",
                        "CRAI",
                        "Lags",
                        "Q1 Earnings",
                        "Estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consulting"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Hereâ€™s What Hedge Funds Think About Adaptimmune Therapeutics plc (ADP)",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Adaptimmune Therapeutics",
                        "plc",
                        "ADP"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}